8.695
1.86%
-0.165
Schlusskurs vom Vortag:
$8.86
Offen:
$8.8
24-Stunden-Volumen:
10,642
Relative Volume:
0.09
Marktkapitalisierung:
$557.45M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-159.39M
KGV:
-
EPS:
-
Netto-Cashflow:
$-105.22M
1W Leistung:
-12.70%
1M Leistung:
-17.19%
6M Leistung:
-39.24%
1J Leistung:
-18.20%
Abivax Adr Stock (ABVX) Company Profile
Vergleichen Sie ABVX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
ABVX | 8.695 | 557.45M | 0 | -159.39M | -105.22M | 0.00 |
VRTX | 447.00 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 742.11 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 588.93 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 249.68 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 103.55 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-14 | Eingeleitet | Leerink Partners | Outperform |
2023-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Abivax Adr Aktie (ABVX) Neueste Nachrichten
Abivax Initiates $150 Million ATM Program on Nasdaq - TipRanks
Abivax Reports Strong Q3 Financials and Clinical Progress - TipRanks
Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News
Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.
Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks
Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks
DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire
Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN
Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Abivax SA Details Financial Struggles and Advances - TipRanks
Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks
Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.
Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks
Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks
Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com
Abivax SA Secures Funding and Expands Operations - TipRanks
Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire
Finanzdaten der Abivax Adr-Aktie (ABVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):